# Medication Treatment for Opioid Use Disorder in Expectant Mothers: Conceptual Model Assessments Sub-study

> **NCT03911466** · — · COMPLETED · sponsor: **T. John Winhusen, PhD** · enrollment: 97 (actual)

## Conditions studied

- Opioid-Related Disorders
- Drug Addiction
- Pregnancy Related
- Substance Abuse
- Drug Abuse
- Neonatal Abstinence Syndrome
- Neonatal Opioid Withdrawal Syndrome
- Drug Abuse in Pregnancy

## Interventions

- **DRUG:** Buprenorphine Injection
- **DRUG:** Buprenorphine Sublingual Product

## Key facts

- **NCT ID:** NCT03911466
- **Lead sponsor:** T. John Winhusen, PhD
- **Sponsor class:** OTHER
- **Phase:** —
- **Study type:** OBSERVATIONAL
- **Status:** COMPLETED
- **Start date:** 2020-07-21
- **Primary completion:** 2024-11-06
- **Final completion:** 2024-11-06
- **Target enrollment:** 97 (ACTUAL)
- **Last updated:** 2026-03-16

## Collaborators

- [object Object]
- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT03911466

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT03911466, "Medication Treatment for Opioid Use Disorder in Expectant Mothers: Conceptual Model Assessments Sub-study". Retrieved via AI Analytics 2026-08-11 from https://api.ai-analytics.org/clinical/NCT03911466. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*